dalteparin has been researched along with Cockett Syndrome in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, BY | 1 |
| Moon, AS | 1 |
| Vasquez, R | 1 |
| Warrier, R | 2 |
| Alva, H | 1 |
| Goyeneche, N | 1 |
| Fletcher, M | 1 |
2 other studies available for dalteparin and Cockett Syndrome
| Article | Year |
|---|---|
Acute Onset of Unilateral Edema of Leg Followed by Hemiplegia in an Adolescent: A Case Report.
Topics: Adolescent; Angioplasty; Anticoagulants; Balloon Valvuloplasty; Diagnosis, Differential; Edema; Enox | 2018 |
Sports Injury or Venous Thrombosis?
Topics: Adolescent; Anticoagulants; Arm; Arthralgia; Athletic Injuries; Compression Bandages; Diagnosis, Dif | 2019 |